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strategy (TST), progression-free survival (PFS) and overall 
survival (OS) were calculated from the start of SBRT to the date 
of the event or last follow-up. Kaplan-Meier method was used. A 
univariate and multivariable Cox proportional hazard model was 
performed to determine predictors of outcomes. A two-tailed p-
value ≤ 0.05 was considered statistically significant. 
Results:  The median follow-up was 14.8 months. Median age was 
66.5 years. The most common primary sites were colorectal (52), 
breast (16), lung (12) and renal cell (6). Median BED10 was 
92.7Gy (59-102). All patients were able to complete prescribed 
therapy. None of the patients developed Grade 3+ toxicity. For 
the OM subgroup (90 lesions), actuarial LC at 1 year was 79.5% 
(71-89%). BED10 ≥ 80 Gy (HR: 2.15, 95%CI: 1.1-4.0, p=0.0175) 
predicted for higher LC. The median TLF was 20 months (11-44) 
for OM patients. At 1 year, the probability of no change in ST 
strategy was 64.7% (55-74). The median TST was 11.1 months 
(8.2-13.9) for the entire cohort. For the OM subgroup (60 
patients), the probability of no change in ST at 1 year was 82.1% 
(72-92) compared to the OP group (40.3%). The actuarial 1 year 
PFS was 42% (31-57%) for OM, and 11.8% (5-30%) for OP patients, 
respectively. Treatment indication predicted for higher PFS, OM 
vs. OP (HR: 2.16, 95% CI: 1.36-3.4, p-value 0.001). Median OS was 
25.2 months (16-41). Primary colorectal cancer (p=0.0456) and 
treatment indication predicted for OS on univariate, but only 
treatment indication remained significant on multivariate 
analysis (OM vs. OP HR: 2.48, 95 %CI: 1.34-4.58 p=0.0037). 
Conclusions:  Outcomes for liver metastases treated with SBRT 
are favorable. Liver SBRT may delay the need to start or change  
ST, and warrants further prospective evaluation. 
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Purpose: The optimal management for limited, non-resectable 
brain metastases is an evolving area in radiation oncology. 
Previous data from randomized trials showed no difference in 
overall survival between radiation treatment with SRS and SRS + 
WBRT. Therefore patient preference plays an important role in 
decision making. This study uses a patient-centred approach to 
elicit patient preferences and understand what factors patients 
consider important in deciding which treatment to pursue.  
Methods and Materials: Patients were eligible for the study if all 
the following criteria were met: maximum of four brain lesions, 
RPA class 1 or 2, and the physician believes either treatment is 
appropriate and maintains an equipoise when discussing 
treatment options. Patients were excluded if they had brain 
metastases that were previously treated. All enrolled patients 
were presented with a decision board instrument which 
describes the two treatments and summarizes the evidence from 
the major trials regarding disease control and toxicity profiles. 
The patients reviewed the information and were able to ask 
questions at the initial consultation. The patients then had the 
option to either take an active role or passive role in further 
decision making. If taking a passive role, this decision was left to 
the clinician. If taking an active role, they would make the 
decision about whether to receive SRS alone, or in combination 
with WBRT. All patients who took an active role in management 
completed a debriefing questionnaire to rank from 0-10 how 
important 10 factors were in making their decision.  
Results: Between two centres in Canada and USA, 23 patients 
who were eligible to receive radiosurgery for brain metastases 
were enrolled in the study. All enrolled patients preferred to 
take an active role in deciding their treatment. The majority of 
patients (21/23) chose to receive SRS alone and two of 23 
patients chose to receive SRS + WBRT. From the debriefing 
questionnaire, the highest ranked factors were quality of life 
(avg = 9.4, SD = 1.03), ability to maintain functional 
independence (avg = 9.3, SD = 0.83) and influence of treatment 
on survival (avg = 9.2, SD = 1.87). The least important factor was 
number of trips required to the cancer centre (avg = 5.0, SD = 
4.22) 
Conclusions: A patient-centred approach to decision making in 
brain metastases is feasible and the majority of patients will 
choose to take an active role in management if all the relevant 
information and evidence is presented in a clear, understandable 
manner. The results of this study show that the majority of 
patients prefer SRS alone in comparison to SRS + WBRT and rank 
quality of life, ability to maintain functional independence and 
influence of treatment on survival as highly important factors in 
making their decision. 
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Purpose:  Bolus is a tissue-equivalent material used in 
radiotherapy to increase the radiation dose delivered to the skin 
surface or to compensate for irregular tissue shape or missing 
tissue. Although using commercially available bolus material is 
an effective and widely used approach, significant shortcomings 
include an inability of standard bolus to perfectly conform to 
very irregular surfaces, creation of air gaps between the skin 
surface and bolus, availability of only limited uniform 
thicknesses and long setup times required to construct complex 
pieces of bolus material for difficult treatment areas. We aimed 
to address these shortcomings by using 3D printer technology in 
combination with an optical scanner to create precise and rigid 
boluses. 
Methods and Materials:  Detailed optical images of non-patient 
volunteers involved in this study were acquired using a 
consumer-grade optical scanner (3D Systems, Sense). A three-
dimensional model of each volunteer was exported to a mesh 
editing software (Autodesk, MeshMixer v2.9) where the bolus was 
designed. The resulting bolus was exported as an STL file to 
software controlling the printer (Repetier-Host), converted to 
gcode (Slic3r) and printed on a consumer-Grade 3D printer 
(MakerGear, M2). Various rigid boluses were printed using 
polylactic acid (PLA). 
Results:  We used images acquired with the optical scanner to 
create rigid boluses for two separate regions. The first was a 
bolus for the nose which was straight forward to make and fit 
very well. The second and more complex was a bolus for the ear. 
In this case, we obtained a better fit by first filling the auditory 
canal with dental impression material. The resulting bolus had 
three parts, but was easily positioned and was a good fit. The 
field outline was printed directly onto this bolus. 
Conclusions:  The use of 3D printing technology shows great 
promise. By using the optical scanner during an initial 
consultation with the physician, one could eliminate the need for 
the patient to return for a clinical set up or mould room 
appointment. The printed bolus greatly reduces the skin-bolus 
air gap due to a personalized and tight fit to the skin surface. 
Any desired thickness of bolus material can be generated 
depending on the depth that needs to be treated and energy of 
radiation that is being used. We are not limited by the 
commercially available bolus materials, which can usually only 
be used in increments of 0.5 cm. Using this technology allows 
boluses to be made easily for complex skin surfaces. It is 
anticipated that the daily setup time on machine will be 
reduced, saving valuable treatment room time. The quality 
assurance process and dosimetric studies have been done and we 
are in the process of developing protocols for clinical 
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implementation. 
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ASSESSING THE PERFORMANCE OF DEFORMABLE IMAGE 
REGISTRATION FOR PELVIS  
Vickie Kong, Joanne Moseley, Tim Craig, Peter Chung, Charles 
Catton 
Princess Margaret Cancer Centre, Toronto, ON 
Purpose: The accumulated delivered dose to mobile organs can 
be estimated by the use of Deformable Image Registration (DIR). 
This study assessed the quality of CT-Cone Beam CT (CBCT) DIR 
based on inclusion of various guiding volumes and/or points for 
the pelvic region. 
Methods and Materials: Reference CT and 13 CBCTs from each 
of 13 prostate patients with intraprostatic fiducial markers (IFM) 
were retrieved. Prostate, bladder and rectum were delineated 
on all image datasets. Each CBCT was deformed to the CBCT 
using DIR by the following: 1) image intensity; 2) 3 IFMs as the 
guiding points (POIG); 3) bladder and rectum as the guiding 
volumes (VOIG); and 4) VOIG+POIG. For each DIR, ProstateDIR, 
BladderDIR, and RectumDIR were generated and compared with 
the manually delineated volumes on CBCT. Distance between 
surfaces (DSS) < 2 mm is considered as having good agreement 
between the volumes. 
Results: A total of 2028 volumes were generated for analysis. 
Volumes generated by DIR using image intensity had the lowest 
agreement (Range of Mean DSS: ProstateDIR = 2 – 6 mm; 
BladderDIR = 6 – 23 mm; RectumDIR = 2 – 6 mm). The use of POIG 
decreased the DSS for ProstateDIR but had no impact on either 
BladderDIR or RectumDIR. Agreement of these volumes increased 
when VOIG or VOIG+POIG was used (Range of Mean DSS: 
ProstateDIR = 1 – 2 mm; BladderDIR = 0.9 – 1 mm; RectumDIR = 
0.1 – 0.6 mm). Difference between VOIG and VOIG+POIG was not 
statistically significant (p = 0.6). 
Conclusions: CT-CBCT DIR using VOIG and VOIG+POIG resulted in 
the smallest difference between volumes. There is no additional 
benefit of including guiding points when guiding volumes are 
used to perform DIR. Impact of interobserver variability in 
contouring guiding volumes on DIR needs to be further 
investigated. 
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RETROSPECTIVE ANALYSIS OF INTER-FRACTIONAL WEIGHT LOSS 
AND SETUP UNCERTAINTIES FOR HEAD AND NECK CANCER 
PATIENTS  
Sarah Weppler, Wendy Smith, Colleen Schinkel 
University of Calgary, Calgary, AB 
Purpose: The major barrier to widespread adoption of adaptive 
radiation therapy (ART) is the difficulty of determining which 
patients would benefit from treatment re-planning. As a 
preliminary step in designing an ART protocol, our centre 
recently began to acquire weekly cone beam computed 
tomography (CBCT) images for head and neck patients. In this 
work, we analyzed each CBCT for the purpose of suggesting 
future ART protocols and re-plan trigger points. 
Methods and Materials: We performed a qualitative 
retrospective analysis of the CBCT scans of fifteen head and neck 
cancer patients flagged for possible treatment re-planning 
between December 2015 and February 2016. All CBCTs were 
initially flagged by therapists for further review by medical 
physicists and radiation oncologists if a patient exhibited a body 
contour change greater than 1.5 cm. 
Results: Overall, the observed contour changes ranged from 1.5 
cm to 3.1 cm with the greatest variability occurring at the 
clavicle and acromion. The primary goal of weekly CBCT imaging 
was to track the effects of weight loss during treatment, 
however in many cases it was difficult to resolve the differences 
between patient setup uncertainties and anatomical changes. 
While head and neck immobilization is highly effective at the 
beginning of treatment, weight loss was seen to exacerbate 
setup uncertainty in later fractions. For example, contour 
changes of 2.4 cm and 2.9 cm in the left and right shoulders, and 
1.2 cm and 1.6 cm in the left and right cheeks, respectively, 
were accompanied by an anteroposterior change in chin position 
of 1.2 cm. PTV contours exceeded the skin by 1.6 cm in this case 
due to the combined effect of weight loss and setup variability. 
The limited field of view of CBCT images further contributed to 
the uncertainty in our analysis; a match of the humeral head or 
other bony landmark to distinguish weight loss from set up errors 
in the shoulders and lower neck was not always possible as a 
result. In addition, we noted that a 1.5 cm change in body 
contour could correspond to a wide range of dosimetric 
implications, ranging from relatively minor to potentially 
significant changes in PTV coverage and healthy tissue sparing. 
Therefore, to build off of the current 1.5 cm criteria, we propose 
that the CBCT data be further analyzed to derive dosimetric and 
anatomical correlations, both within CBCT images and among 
multiple CBCT data sets. Given the large amount of data 
available from the current ART weekly CBCT protocol, machine 
learning and optimization-based methods will likely be the most 
effective means of optimally designing the re-plan trigger points. 
Conclusions: It is widely hypothesized that efficient ART 
methods will serve a vital role in the improvement of treatment 
quality. We propose that the next development of the ART 
protocol at our centre be derived from deformable image 
registration and subsequent machine learning-based analysis of 
the weekly CBCT scans. 
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SALVAGE I-125 LDR PROSTATE BRACHYTHERAPY 
REIMPLANTATION FOR LOCAL FAILURE USING INTRAOPERATIVE 
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Michael Peacock1, Amandeep Taggar1, Kevin Martell1, Steve 
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Purpose: There are few reports in the literature of salvage 
reimplantation prostate brachytherapy following local failure. 
We report on our institutional experience performing salvage 
reimplantation using LDR intraoperative planning for locally 
recurrent prostate cancer. 
Methods and Materials: From 2003-2014, seven out of 823 
patients with low- and intermediate-risk localized prostate 
cancer treated with brachytherapy underwent a salvage 
reimplantation for biochemical failure and biopsy confirmed 
recurrence. Restaging included a 3.0 T MRI of the prostate and 
pelvis prior to reimplantation. Patients were treated with an LDR 
intraoperative planning technique using I-125 seeds. The 
prostate was prescribed 144 Gy and the area of recurrence, as 
detected on biopsy and MRI, was contoured as an area of interest 
and was the only area covered by the 150% isodose. The base of 
the seminal vesicles were implanted if felt to be involved. The 
intraoperative urethral V120 dose was reduced to 0%. Descriptive 
statistics were used to summarize the results. 
Results: Intraoperative dosimetry for the first implant showed 
excellent coverage with a median D90 prostate and V100 of 190 
Gy and 99.8% respectively. The median follow up time from 
initial diagnosis was 10 years (range, 6.1-12.2) and 2.1 years from 
the time of the second implant. Median time from initial implant 
to second Implant was 6 years (range 4.2-9.2). Mean PSA at time 
of reimplantation was 6.0 ng/ml (range, 3.9-13.3). Five of the 
seven reimplanted patients achieved biochemical control with a 
PSA nadir of < 0.1 ng/ml. Three patients developed urinary 
toxicity requiring intervention within 24 months following 
treatment including two undergoing transurethral resection of 
prostate and one temporary catheterization for urinary 
obstruction. 
Conclusions: A salvage reimplantation for recurrent prostate 
cancer in select patients with biopsy confirmed local recurrence 
can achieve biochemical control. Patients are at increased risk 
of urinary toxicity requiring intervention. A salvage 
reimplantation at an experienced centre should be considered as 
a local salvage option following local failure after prostate 
brachytherapy. 
